---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-028744"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2026-08-21T20:34:49+00:00"
generated_at: "2026-08-21T20:35:36.887689+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioCardia receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq notice on Aug 19, 2026; bid price below $1.00 for 30 consecutive business days.
- Granted 180 days until Feb 16, 2027 to regain compliance via $1.00+ closing bid for 10 straight days.
- No immediate impact on listing; company may pursue reverse stock split if needed.
- Failure to cure could lead to delisting, with eligibility for additional 180-day period or hearing appeal.

## SEC filing metadata
- accession: 0001437749-26-028744
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2026-08-21T20:34:49+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774926028744/0001437749-26-028744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774926028744/bcda20260819_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-028744
- JSON: https://secwatch.observer/filing/0001437749-26-028744.json
- Plain text: https://secwatch.observer/filing/0001437749-26-028744.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.